This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schwarz, R. E. Articles by Smith, D. D. Search for Related Content PubMed PubMed Citation Articles by Schwarz, R. E. Articles by Smith, D. D.

Extent of Lymph Node Retrieval and Pancreatic Cancer Survival: Information from a Large US Population Database

¹ Division of Surgical Oncology, The Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, New Jersey 08903, USA
² Division of Biostatistics, City of Hope Cancer Center, 1500 E. Duarte Road, Duarte, California 91010, USA

Correspondence: Address correspondence and reprint requests to: Roderich E. Schwarz, MD; E-mail: r.schwarz{at}umdnj.edu

Background: Operative therapy of pancreatic cancer is associated with poor survival because of high recurrence rates after pancreatectomy. The effect of lymph node (LN) dissection on survival continues to be debated.

Methods: A pancreatic cancer data set was created through structured queries to the Surveillance, Epidemiology, and End Results 1973 to 2000 database. Stage information was created according to 6th edition American Joint Committee on Cancer tumor-node-metastasis criteria, and the effect of LN number on survival was analyzed.

Results: Out of a cohort of 20,631 patients with carcinomas of the exocrine pancreas, surgical details were available for 2,787 patients. Procedures included pancreatoduodenectomies (n = 1848; 66%), radical regional pancreatectomies (n = 516; 19%), other partial resections (n = 316; 11%), and total pancreatectomies (n = 107; 4%). For 1666 of these patients with complete clinicopathologic information, the median age was 66 years (range, 22–96 years), with an equal sex ratio. The median number of total LNs examined was 7 (range, 1–52), of positive LNs was 1 (range, 0–34), and of negative LNs was 6 (range, 0–30). Multivariate survival analysis yielded these prognostic variables: number of LNs examined, number of positive LNs, tumor size, extrapancreatic extension, radiotherapy (all P < .0001), and age (P = .0009). The greatest survival differences were observed for negative LN counts of 10 to 15.

Conclusions: Stage-based survival prediction of pancreatic cancer is strongly influenced by total LN counts and numbers of negative LNs obtained. Although the mechanism remains unclear and could reflect confounding factors (margin status and institutional volume), an attempt to resect and examine at least 15 LNs to yield preferably between 10 and 15 negative LNs seems sensible for curative-intent pancreatectomy.

Key Words: Pancreatic cancer • Postoperative survival • Lymph node counts • Lymphadenectomy • SEER population data

This article has been cited by other articles:

				From the Cover: Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis PNAS, July 8, 2008; 105(27): 9343 - 9348.

				K. Y. Bilimoria, M. S. Talamonti, J. D. Wayne, J. S. Tomlinson, A. K. Stewart, D. P. Winchester, C. Y. Ko, and D. J. Bentrem Effect of Hospital Type and Volume on Lymph Node Evaluation for Gastric and Pancreatic Cancer Arch Surg, July 1, 2008; 143(7): 671 - 678. [Abstract] [Full Text] [PDF]

				K. Y. Bilimoria, C. M. Balch, D. J. Bentrem, M. S. Talamonti, C. Y. Ko, J. R. Lange, D. P. Winchester, and J. D. Wayne Complete Lymph Node Dissection for Sentinel Node-Positive Melanoma: Assessment of Practice Patterns in the United States Ann. Surg. Oncol., June 1, 2008; 15(6): 1566 - 1576. [Abstract] [Full Text] [PDF]

				M. B. Slidell, D. C. Chang, J. L. Cameron, C. Wolfgang, J. M. Herman, R. D. Schulick, M. A. Choti, and T. M. Pawlik Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis Ann. Surg. Oncol., January 1, 2008; 15(1): 165 - 174. [Abstract] [Full Text] [PDF]

				A. Govindarajan, J. C. C. Tan, N. N. Baxter, N. G. Coburn, and C. H. L. Law Variations in Surgical Treatment and Outcomes of Patients With Pancreatic Cancer: A Population-Based Study Ann. Surg. Oncol., January 1, 2008; 15(1): 175 - 185. [Abstract] [Full Text] [PDF]

				R. Ricciardi and N. N. Baxter Association Versus Causation Versus Quality Improvement: Setting Benchmarks for Lymph Node Evaluation in Colon Cancer J Natl Cancer Inst, March 21, 2007; 99(6): 414 - 415. [Full Text] [PDF]